Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

The StockTalk Cannabis Report: June 18, 2021

Dave Jackson June 18, 2021

Next Super Stocks on the Move: Tetra Bio-Pharma, Red Light Holland, FansUnite, and Skylight Health

GlobeNewswire June 11, 2021

The StockTalk Cannabis Report: June 11, 2021

Dave Jackson June 11, 2021

The StockTalk Cannabis Report: June 4, 2021

Dave Jackson June 4, 2021

Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting

Accesswire June 2, 2021

Tetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting

Canada NewsWire May 28, 2021

The StockTalk Cannabis Report: May 28, 2021

Dave Jackson May 28, 2021

Tetra Bio-Pharma Announces Clinical Advancements and Establishment of At-the-Market Equity Program

Canada NewsWire May 28, 2021

Tetra Bio-Pharma Announces Exercise of Over-Allotment Option in Connection with Bought Deal Financing

Canada NewsWire May 21, 2021

Tetra Bio-Pharma Inc. Announces Changes to its Board of Directors and the Filing of a Supplement to its Management Information Circular

Canada NewsWire May 18, 2021

Tetra Bio-Pharma Announces Closing of Bought Deal Offering

Canada NewsWire May 17, 2021

The StockTalk Cannabis Report: May 14, 2021

Dave Jackson May 14, 2021

NEXT SUPER STOCKS on The Move: FansUnite, Reliq Health Tech, Hapbee, and Tetra Bio-Pharma

GlobeNewswire May 12, 2021

Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain

Accesswire May 11, 2021

Tetra Bio-Pharma Announces $10 Million "Bought Deal" Public Offering

Canada NewsWire May 10, 2021

NEXT SUPER STOCKS on The Move: Tetra Bio-Pharma, Relay Medical, Victory Square Technologies, and Red Light Holland

GlobeNewswire May 7, 2021

Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial

Accesswire May 6, 2021

Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios

Accesswire May 5, 2021

Tetra Bio-Pharma (TSX:TBP) re-activates veterinary clinical study in companion animals

John Ballem  May 4, 2021

Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals

Accesswire May 4, 2021